Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Katherine Doores"'
Autor:
Katherine Doores, Judith Heaney, Laura E. McCoy, Annachiara Rosa, Luke Muir, Eleni Nastouli, N Lee, Peter Cherepanov, Chloe Roustan, Jeffrey Seow, Philip Thomas, Hans J. Stauss, Ravindra K. Gupta, Chloe Rees-Spear, Yoann Aldon, Jonne L. Snitselaar, Carl Graham, MJ van Gils, Rogier W. Sanders, Sarah A. Griffith, Catherine F Houlihan
Multiple SARS-CoV-2 vaccines have shown protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral entry protein, Spike. Antibodies from SARS-CoV-2 infection neutralize the virus by focused targeting of Spike
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::332089f00f4f253a66d1bd77f1f52f5b
https://doi.org/10.1101/2021.01.15.426849
https://doi.org/10.1101/2021.01.15.426849
Autor:
Helena Winstone, Suzanne Pickering, Chad M. Swanson, Katherine Doores, Stuart J. D. Neil, M. J. Lista Brotos, A. Reid
The cellular entry of severe acute respiratory syndrome-associated coronaviruses types 1 and 2 (SARS-CoV-1 and -2) requires sequential protease processing of the viral spike glycoprotein (S). The presence of a polybasic cleavage site in SARS-CoV-2 S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c694874334b3b2f8219cc9ff9a70dbeb
https://doi.org/10.1101/2020.12.19.423592
https://doi.org/10.1101/2020.12.19.423592
Publikováno v:
Journal of Molecular Biology
Seabright, G E, Doores, K J, Burton, D R & Crispin, M 2019, ' Protein and glycan mimicry in HIV vaccine design ', Journal of Molecular Biology, vol. 431, no. 12, https://doi.org/10.1016/j.jmb.2019.04.016, pp. 2223-2247 . https://doi.org/10.1016/j.jmb.2019.04.016
Seabright, G E, Doores, K J, Burton, D R & Crispin, M 2019, ' Protein and glycan mimicry in HIV vaccine design ', Journal of Molecular Biology, vol. 431, no. 12, https://doi.org/10.1016/j.jmb.2019.04.016, pp. 2223-2247 . https://doi.org/10.1016/j.jmb.2019.04.016
Antigenic mimicry is a fundamental tenet of structure-based vaccinology. Vaccine strategies for the human immunodeficiency virus type 1 (HIV-1) focus on the mimicry of its envelope spike (Env) due to its exposed location on the viral membrane and rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191832897ade7cd61f4361effe2a54f6
https://eprints.soton.ac.uk/430318/
https://eprints.soton.ac.uk/430318/
Autor:
Anthony B. Cooper, David Nemazee, Katherine Doores, William R. Schief, Khoa Le, Miyo Aoki-Ota, Colleen Doyle-Cooper, Richard T. Wyatt, Takayuki Ota, Dennis R. Burton
Publikováno v:
The Journal of Immunology. 191:3179-3185
Broadly neutralizing Abs against HIV protect from infection, but their routine elicitation by vaccination has not been achieved. To generate small animal models to test vaccine candidates, we have generated targeted transgenic (“knock-in”) mice e
Autor:
Khoa Le, Ralph Pantophlet, Anthony B. Cooper, Michael Huber, Dennis R. Burton, David Nemazee, Chi-Huey Wong, Colleen Doyle-Cooper, Katherine Doores, Sheng-Kai Wang
Publikováno v:
Journal of Virology. 87:2234-2241
The highly conserved cluster of high-mannose glycans on the HIV-1 envelope glycoprotein, gp120, has been highlighted as a target for neutralizing antibodies. 2G12, the first HIV-1 antiglycan neutralizing antibody described, binds with an unusual doma
Autor:
Benjamin G. Davis, M. G. Finn, Dennis R. Burton, Ian A. Wilson, Vu Hong, Mark R. Wormald, Mitul Patel, Zara Fulton, Katherine Doores, Christopher N. Scanlan
Antibody 2G12 uniquely neutralizes a broad range of HIV-1 isolates by binding the high-mannose glycans on the HIV-1 surface glycoprotein, gp120. Antigens that resemble these natural epitopes of 2G12 would be highly desirable components for an HIV-1 v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52500f7faa5118d8942379e48401a80
https://ora.ox.ac.uk/objects/uuid:e6e5b533-9754-4201-8a48-d740abc65d09
https://ora.ox.ac.uk/objects/uuid:e6e5b533-9754-4201-8a48-d740abc65d09
Autor:
Camille Bonomelli, Victoria E. Thaney, Christopher N. Scanlan, Katherine Doores, Dennis R. Burton, D. Cameron Dunlop, Max Crispin, Raymond A. Dwek
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23521 (2011)
PLoS ONE
PLoS ONE
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design. The extent of cross-clade conservation of HIV oligomannose glycans is therefore a critical consideration for the development of HIV prophylaxes. We m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3faccf198f35d89230ce3f0225135229
https://doi.org/10.1371/journal.pone.0023521
https://doi.org/10.1371/journal.pone.0023521
Autor:
Gerard Tobias, Katherine Doores, Angus I. Kirkland, Malcolm L. H. Green, Sung You Hong, Belén Ballesteros, Farid El Oualid, Peter D. Nellist, Benjamin G. Davis, James C. Errey
Single-walled carbon nanotubes (SWNTs) functionalized with organic molecules bearing high-scattering element tags have allowed direct visualization of modification on the atomic scale. The inclusion of these tags in protecting groups allowed their su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff8c0632f95d70d0a1b4f754708459f
https://doi.org/10.1021/ja069080i
https://doi.org/10.1021/ja069080i
Publikováno v:
Journal of Virology. 84:10690-10699
The broadly neutralizing anti-human immunodeficiency virus type 1 (HIV-1) antibody 2G12 targets the high-mannose cluster on the glycan shield of HIV-1. 2G12 has a unique V H domain-exchanged structure, with a multivalent binding surface that includes
Autor:
Dennis R. Burton, Katherine Doores
Publikováno v:
Journal of Virology. 84:10510-10521
The HIV-1-specific antibodies PG9 and PG16 show marked cross-isolate neutralization breadth and potency. Antibody neutralization has been shown to be dependent on the presence of N-linked glycosylation at position 160 in gp120. We show here that (i)